polyglucosan body myopathy type 2
polyglucosan body myopathy type 2
Explore linked clinical trials. Standard reference: MONDO:00145261 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rare Glycogen Storage Diseases Natural History Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Danon disease, Muscular Disorders, Atrophic, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, X-linked disease, cardiomyopathy, cardiovascular disorder, disorder of glycogen metabolism, glycogen storage disease VII, glycogen storage disease due to aldolase A deficiency, glycogen storage disease due to muscle and heart glycogen synthase deficiency, glycogen storage disease due to muscle beta-enolase deficiency, glycogen storage disease due to phosphoglycerate mutase deficiency, glycogen storage disorder due to hepatic glycogen synthase deficiency, heart disorder, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, intellectual disability, metabolic disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, polyglucosan body myopathy 1 with or without immunodeficiency, polyglucosan body myopathy type 2 | Recruiting | Not stated | 2026-01-07 | NCT06795152 |